SpyGlass Pharma, Inc. (SGP)
$23.92-3.78%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $800M
- Beta
- -0.89
- P/E (TTM)
- -14.41
- Short % float
- 8.99%
- Days to cover
- 7.1
- SI change
- +1.9%
- 1W
- -3.47%
- 1M
- -16.54%
- vs SPY 1W
- -3.33%
- vs SPY 1M
- -19.04%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SGP?
- LOPJLB’s latest quantitative signal on SpyGlass Pharma, Inc. Common Stock (SGP) is SELL. Signals are updated daily.
- What market regime is SGP in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does SpyGlass Pharma, Inc. Common Stock (SGP) do?
- SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure…